Adial Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Adial Pharmaceuticals, Inc. (ADIL) had Operating Leases, Future Minimum Payments, Due in Four Years of $75.23 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2021-05-17
- 2021-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $75.23K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2021-03-31 | $75.23K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |